Madrigal Pharmaceuticals (MDGL) PT Raised to $375 at Oppenheimer
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $480.77 +1.37%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $375.00 (from $320.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- Sky Perfect JSAT Holdings (9412:JP) PT Raised to JPY5,000 at Goldman Sachs
- Oxford Industries (OXM) PT Lowered to $40 at UBS Amid Top-line Weakness
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
